Research News

Medindia's Press Release’ section provides the latest press release on Research from across the world for the global audience. This page links to 10906 Research press releases.

New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults

ATLANTA, Dec. 7 A recent study presented at the Gerontological Society of America's 62nd Annual Scientific Meeting shows that a combination of vitamins and nutriceuticals improves memory and cognitive performance in community-dwelling ...


PharmAthene Presents Phase I Clinical Trial Results and New Therapeutic Animal Model Data for Protexia(R)

ANNAPOLIS, Md., Dec. 7 PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia®, a pegylated recombinant ...

Study on Very Small Embryonic-Like Stem Cell Mobilization Presented at American Society of Hematology Annual Meeting on December 5, 2009

NEW YORK, Dec. 7 NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holds the exclusive, worldwide license to VSEL(TM) technology that ...

AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology

Response Rate Increases to 41% and Median Overall Survival Reported at 25 Months for All Evaluable Patients QUEBEC CITY, Dec. 7 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global ...

Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing

UPPSALA, Sweden and EDISON, N.J., Dec. 7 Q-Med AB and Oceana Therapeutics, Inc. today announced that the SOLESTA(TM) pivotal study succeeded in meeting both primary endpoints for the treatment of fecal incontinence. Q-Med AB and ...

Carfilzomib Demonstrates Encouraging Response Rates in Patients with Relapsed and/or Refractory Multiple Myeloma in an Ongoing Phase 2 Study

NEW ORLEANS, Dec. 7 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib. Results demonstrated promising overall response ...

Research News »

Unveiling the Sulfur Trail: Connections to Neurodegenerative Diseases

Unveiling the Sulfur Trail: Connections to Neurodegenerative Diseases

Neurodegenerative diseases (NDDs), incurable and often of unknown origin, cause irreversible damage to the brain and nervous system. Recent mouse studies indicate that besides brain-focused research, the microbiome may influence the development and ...

Gene-Editing Therapy Advances in Sickle Cell Patients

Gene-Editing Therapy Advances in Sickle Cell Patients

Researchers unveiled the most recent results from a clinical trial designed to find a cure for sickle cell disease, a painful genetic blood disorder with few available treatments. ...

Clear National Blood Policy Ensures Safest Blood for Patients

Clear National Blood Policy Ensures Safest Blood for Patients

A clear national blood policy, supported by collaboration among all stakeholders, is the best way to ensure patients receive the safest possible blood whenever needed. World Blood Donor Day ( ) is observed every year on June 14 to honour and ...

Virus-Based Therapy to Treat Brain Disorders

Virus-Based Therapy to Treat Brain Disorders

Modified viruses in pre-clinical trials offer a new way to replace a deficient brain protein for severe conditions, as published in the journal Science Translational Medicine ( ). Frontotemporal dementia is a currently ...

Is ADHD an Age-Related Immaturity or Disorder?

Is ADHD an Age-Related Immaturity or Disorder?

Younger students are more frequently diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD) than older peers, as teachers might mistake immaturity for disorders, according to a new study published in the ...

More Research News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.